Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Zuraw, Bruce
Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. [electronic resource] - The Journal of allergy and clinical immunology Oct 2010 - 821-827.e14 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1097-6825
10.1016/j.jaci.2010.07.021 doi
Acute Disease
Angioedemas, Hereditary--drug therapy
Complement C1 Inhibitor Protein--administration & dosage
Double-Blind Method
Europe
Female
Humans
Injections, Intravenous
Male
North America
Pain Measurement
Recombinant Proteins--administration & dosage
Treatment Outcome
Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. [electronic resource] - The Journal of allergy and clinical immunology Oct 2010 - 821-827.e14 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1097-6825
10.1016/j.jaci.2010.07.021 doi
Acute Disease
Angioedemas, Hereditary--drug therapy
Complement C1 Inhibitor Protein--administration & dosage
Double-Blind Method
Europe
Female
Humans
Injections, Intravenous
Male
North America
Pain Measurement
Recombinant Proteins--administration & dosage
Treatment Outcome